Literature DB >> 9892201

hMLH1 promoter methylation and lack of hMLH1 expression in sporadic gastric carcinomas with high-frequency microsatellite instability.

S Y Leung1, S T Yuen, L P Chung, K M Chu, A S Chan, J C Ho.   

Abstract

Mutation of DNA mismatch repair genes has rarely been documented in sporadic gastric carcinoma with microsatellite instability (MSI). In sporadic colorectal carcinoma, hMLH1 promoter methylation associated with protein loss is found in the majority of high-frequency MSI cases. We investigated a series of 35 sporadic gastric carcinomas stratified into high-frequency MSI (MSI-H), low-frequency MSI (MSI-L) and microsatellite stable (MSS) groups and found that hypermethylation of the CpG island in the hMLH1 promoter region was present in 100% of MSI-H sporadic gastric carcinomas. In 90% of cases, there was an associated complete loss of hMLH1 protein, as detected by immunohistochemistry, and a markedly lowered hMLH1 mRNA level. This loss of hMLH1 protein occurred in the MSI-H invasive tumor but not in the adjacent carcinoma-in situ or dysplastic components that were MSS. The MSI-L and MSS forms of gastric carcinoma all showed predominantly unmethylated hMLH1 promoter, positive hMLH1 protein and high hMLH1 mRNA level. On the other hand, hMSH2 protein was expressed in all of the tumors irrespective of the MSI status. Our results suggest that high-frequency MSI in sporadic gastric cancer is mostly due to epigenetic inactivation of hMLH1 in association with promoter methylation, and the loss of hMLH1 protein is a significant event in the development of invasive tumor.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9892201

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  84 in total

Review 1.  DNA mismatch repair genes and colorectal cancer.

Authors:  J M Wheeler; W F Bodmer; N J Mortensen
Journal:  Gut       Date:  2000-07       Impact factor: 23.059

Review 2.  Clinical aspect and molecular mechanism of DNA aneuploidy in gastric cancers.

Authors:  Eiji Oki; Yuichi Hisamatsu; Koji Ando; Hiroshi Saeki; Yoshihiro Kakeji; Yoshihiko Maehara
Journal:  J Gastroenterol       Date:  2012-03-09       Impact factor: 7.527

3.  Immunohistochemical expression of mismatch repair genes: a screening tool for predicting mutator phenotype in liver fluke infection-associated intrahepatic cholangiocarcinoma.

Authors:  Upama Liengswangwong; Anant Karalak; Yukio Morishita; Masayuki Noguchi; Thiravud Khuhaprema; Petcharin Srivatanakul; Masanao Miwa
Journal:  World J Gastroenterol       Date:  2006-06-21       Impact factor: 5.742

4.  Differences in genomic instability between intestinal- and diffuse-type gastric cancer.

Authors:  Matti Vauhkonen; Hanna Vauhkonen; Antti Sajantila; Pentti Sipponen
Journal:  Gastric Cancer       Date:  2005       Impact factor: 7.370

5.  Re-expression of methylation-induced tumor suppressor gene silencing is associated with the state of histone modification in gastric cancer cell lines.

Authors:  Chun-Feng Meng; Xin-Jiang Zhu; Guo Peng; Dong-Qiu Dai
Journal:  World J Gastroenterol       Date:  2007-12-14       Impact factor: 5.742

6.  Comparative Molecular Analysis of Gastrointestinal Adenocarcinomas.

Authors:  Yang Liu; Nilay S Sethi; Toshinori Hinoue; Barbara G Schneider; Andrew D Cherniack; Francisco Sanchez-Vega; Jose A Seoane; Farshad Farshidfar; Reanne Bowlby; Mirazul Islam; Jaegil Kim; Walid Chatila; Rehan Akbani; Rupa S Kanchi; Charles S Rabkin; Joseph E Willis; Kenneth K Wang; Shannon J McCall; Lopa Mishra; Akinyemi I Ojesina; Susan Bullman; Chandra Sekhar Pedamallu; Alexander J Lazar; Ryo Sakai; Vésteinn Thorsson; Adam J Bass; Peter W Laird
Journal:  Cancer Cell       Date:  2018-04-02       Impact factor: 31.743

Review 7.  Helicobacter pylori eradication to prevent gastric cancer: underlying molecular and cellular mechanisms.

Authors:  Shingo Tsuji; Masahiko Tsujii; Hiroaki Murata; Tsutomu Nishida; Masato Komori; Masakazu Yasumaru; Shuji Ishii; Yoshiaki Sasayama; Sunao Kawano; Norio Hayashi
Journal:  World J Gastroenterol       Date:  2006-03-21       Impact factor: 5.742

Review 8.  Epigenetic Mechanisms and Events in Gastric Cancer-Emerging Novel Biomarkers.

Authors:  Hasan Raza Kazmi; Soni Kumari; Satendra Tiwari; A Khanna; Gopeshwar Narayan
Journal:  Pathol Oncol Res       Date:  2018-03-19       Impact factor: 3.201

9.  Geno- and pheno-typic characterization in ten patients with double-primary gastric and colorectal adenocarcinomas.

Authors:  Jin C Kim; Kum H Koo; Hee C Kim; Jung S Kim; Gyeong H Kang
Journal:  Int J Colorectal Dis       Date:  2004-04-09       Impact factor: 2.571

10.  Epigenetic-genetic interactions in the APC/WNT, RAS/RAF, and P53 pathways in colorectal carcinoma.

Authors:  Yutaka Suehiro; Chi Wai Wong; Lucian R Chirieac; Yutaka Kondo; Lanlan Shen; C Renee Webb; Yee Wai Chan; Annie S Y Chan; Tsun Leung Chan; Tsung-Teh Wu; Asif Rashid; Yuichiro Hamanaka; Yuji Hinoda; Rhonda L Shannon; Xuemei Wang; Jeffrey Morris; Jean-Pierre J Issa; Siu Tsan Yuen; Suet Yi Leung; Stanley R Hamilton
Journal:  Clin Cancer Res       Date:  2008-05-01       Impact factor: 12.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.